Twenty strains of avian mycoplasma, representing 12 serotypes, were tested in vitro for their susceptibility to the action of lincomycin and spectinomycin alone and in combination. They varied in their sensitivity pattern. The ranges of minimal inhibitory concentration were 1 to 20 ,ug/ml for lincomycin or spectinomycin alone and 0.5/1 to 3/6 ,ug/ml for the lincomycin and spectinomycin combination. The ranges of minimal lethal concentration were greater with either single antibiotic than with the antibiotic combination. The amount of each antibiotic required to achieve mycoplasmacidal action of the relatively resistant strains was less with the antibiotic combination than with the single antibiotics.
:plasma has been classified by several investiga--tors (1, 5, 8, 9) . They have been characterized and grouped into 12 serotypes designated A through L (9) . The lincomycin and spectinomycin combination was found to be effective against airsacculitis of chickens and turkeys caused by Mycoplasma gallisepticum and M. meleagridis (2, 3) .
It is the purpose of this communication to report the in vitro susceptibility of 20 strains of avian mycoplasma to the action of lincomycin and spectinomycin alone and in combination. MATERIALS Media. Three culture media were used. A medium containing 88.5% phenol red broth base (Difco), 1% yeast extract, 0.5% dextrose, and 10% inactivated horse serum was used to determine the MIC for the dextrose fermenters. Another mycoplasma broth medium containing 89.5% mycoplasma broth base (Albimi Laboratories), 0.5% yeast extract, and 10% inactivated horse serum was used for the dextrose nonfermenters. The MLC was determined in a modified mycoplasma agar medium containing 88.0% mycoplasma broth base (Albimi Laboratories), 0.5% yeast extract, 1.5% agar (Difco), and 10% inactivated horse serum.
Procedure. The broth medium was dispensed in 4.5-ml amounts in sterile tubes and 0.5 ml of the antibiotic dilution was added to make a final concentration of 20, 10, 9, 7, 6, 5, 3, 1, 0.1, 0.01 ug/ml of broth. A 0. second or third time after at least 7 days of incubation.
The effect of lincomycin and spectinomycin alone and in various combinations was evaluated against M. gallisepticum (strain S-6 JF) by using the "block test design" in 4.5 ml of phenol red broth and 0.5 ml of the antibiotic dilution. The test was carried out in duplicate. The final concentration of the antibiotic was 1 to 20 Ag/ml for lincomycin and spectinomycin.
The antibiotic-medium mixture was inoculated with 0.1 ml of a 48-hr broth culture of strain S-6 JF. The tubes were examined daily for visible growth or inhibition. After 2, 4, and 6 days of incubation, a loopful from each tube was streaked on agar plates, sealed, and incubated for a period of 7 to 10 days. The plates were examined microscopically for mycoplasma. RESULTS
The susceptibility of 20 strains of avian mycoplasma to lincomycin and spectinomycin alone 'VOL. 20, 1970 Spectinomycin (jg/ml) and in combination is shown in Tables 2 and 3 . The MIC was determined for 13 strains which fermented dextrose. The ranges of MIC varied from 1 to 10 ug/ml for lincomycin alone, with an average of 4.1 ,ug/ml; 1 to 20 ,ug/ml for spectinomycin alone, with an average of 6.8 gg/ml; and 0.5/1 to 3/6 j,g/ml for the lincomycin-spectinomycin combination, with an average of 1.25/ ,,Symbols: +, microscopic growth; -, no microscopic growth; (-), MLC. spectinomycin alone; and 0.5/1 to 10/20 ,ug/ml for the lincomycin-spectinomycin combination (Table 3) . At 20 Ag/ml, three serotypes (D, E, and I) were resistant to lincomycin and spectinomycin when tested separately, one unclassified dextrose fermenter was resistant to lincomycin alone, and three more serotypes (A, B, and J) were resistant to spectinomycin alone ( Table 3) .
All of the strains tested were sensitive to the lincomycin-spectinomycin combination.
The antimycoplasmal effect of combined lincomycin and spectinomycin as compared to the individual components was determined against strain S-6 IF, A serotype (Tables 4 and 5 ). The MIC (recorded after 2 days of incubation) was 2 ,ug/ml for lincomycin or spectinomycin when tested singly and 1/1 ,ug/ml for the lincomycinspectinomycin combination. The MIC (recorded after 5 to 7 days of incubation) was 7 ,g/ml for lincomycin, 3 Ag/ml for spectinomycin, and 1/2 ,ug/ml for the lincomycin-spectinomycin combination. The MLC was 10 ,g/ml for lincomycin, 5 ,ug/ml for spectinomycin, and 1/3 ,g/ml for the lincomycin-spectinomycin combination.
Other MLC values of the antibiotic combination were also recorded (Table 5) .
DISCUSSION
The results obtained from this study indicate the differences in susceptibility of several strains and serotypes of avian mycoplasma to the action of the antibiotics tested. These data are in general agreement with those reported by others (6, 7) . Perlman et al. (6) and Rahman et al. (7) concluded that Mycoplasma species isolated from tissue cultures vary widely in their antibiotic susceptibility pattern. In our studies, the ranges of MIC and MLC were greater with lincomycin or spectinomycin alone than with lincomycin and spectinomycin in combination. In addition, some strains were more sensitive to one antibiotic than the other, indicating strain to strain variability to the action of antibiotics. Furthermore, relatively resistant strains, as defined by MLC values greater than 20 ug/ml, were noted only with the single antibiotics as shown in 20% of the strains tested against lincomycin alone and 35% of the strains tested against spectinomycin alone. It is interesting to note that with the antibiotic combination the amount of each antibiotic required to achieve mycoplasmacidal activity against relatively resistant strains was smaller than with the individual components tested alone. This was clearly illustrated in 5 of 20 strains representing A, B, D, E, and I serotypes that required 20 ,g/ml or more of the single antibiotic but 1.5/3 to 5/10 ,ug/ml for the lincomycin-spectinomycin combination. It appeared that greater mycoplasmacidal action was achieved in 45% of the strains tested with the lincomycin-spectinomycin combination than with the single antibiotics. It has been suggested that the use of an antibiotic combination has several potential advantages for antimicrobial therapy, including enhancement of antimicrobial spectrum, especially in serious infections of undetermined or complicated etiology, possible synergistic activity, and reduction or prevention of emergence of resistant microorganisms (4) . The lincomycin-spectinomycin combination has a wider range of activity against gram-negative and gram-positive bacteria as well as mycoplasma than the individual components.
The results obtained from the antimycoplasmal action of lincomycin and spectinomycin alone and in various combinations indicate that the biochemical processes of the organisms were slowed by the drug action. However, mycoplasmacidal action was achieved with less lincomycin in the antibiotic combination than with lincomycin alone. These data suggest that one part lincomycin to two or three parts spectinomycin appeared to be the optimum ratio. Lincomycin and spectinomycin combined in a one to two ratio was more effective than the single antibiotics in chickens experimentally infected with mycoplasma and Escherichia coli (2) . These evaluations were based on increasing the survival rate, reducing the gross lesions of airsacculitis, and improving the weight gain. Similar results were also obtained in turkey poults naturally infected with M. meleagridis ("H" serotype) and treated with the antibiotic combination (3). The data obtained from both in vitro and in vivo studies indicate the superiority of the lincomycinspectinomycin combination over the single antibiotics.
